# Debate Matchup Judgment Report

**Claude Sonnet 5 (high)** vs **GPT-6 Astra (high)**

- Paired result: **GPT-6 Astra (high)**
- Mean entertainment: `7.50 / 10`
- Judge decisions: `6` across two side-swapped debates

**Motion:** For carefully screened adolescents with persistent gender dysphoria, access to gender-affirming medical care improves mental-health outcomes more than it increases long-term regret or harm.

## Debates and evidence

- [Debate A transcript](../../../transcripts/prop_0107__claude-sonnet-5-high__gpt-6-astra-high__s0__tpl_placement_active_20260813a.md): PRO = **Claude Sonnet 5 (high)**, CON = **GPT-6 Astra (high)**
- [Debate B transcript](../../../transcripts/prop_0107__gpt-6-astra-high__claude-sonnet-5-high__s1__tpl_placement_active_20260813a.md): PRO = **GPT-6 Astra (high)**, CON = **Claude Sonnet 5 (high)**
- [Public judge decision table](../../../judgments/judge_results__judge_blend_glm53_coverage_20260904a.csv)

## Debate A

- Transcript: [read the full debate](../../../transcripts/prop_0107__claude-sonnet-5-high__gpt-6-astra-high__s0__tpl_placement_active_20260813a.md)
- Roles: PRO = **Claude Sonnet 5 (high)**, CON = **GPT-6 Astra (high)**
- Judged result: Unanimous `3-0` for **GPT-6 Astra (high)**.
- Entertainment scores: `8`, `7`, `7`
- Mean signed raw margin (PRO+): `-1.83`

| Judge | Presented sides | Winner | Signed Margin (PRO+) | Normalized | Entertainment |
| --- | --- | --- | ---: | ---: | ---: |
| Gemini 3.1 Pro Preview | A = GPT-6 Astra (high) (CON); B = Claude Sonnet 5 (high) (PRO) | GPT-6 Astra (high) | -1.8 | -1.53 | 8.0 |
| Grok 4.5 (high) | A = Claude Sonnet 5 (high) (PRO); B = GPT-6 Astra (high) (CON) | GPT-6 Astra (high) | -1.7 | -1.93 | 7.0 |
| Muse Spark 1.1 (high) | A = GPT-6 Astra (high) (CON); B = Claude Sonnet 5 (high) (PRO) | GPT-6 Astra (high) | -2.0 | -2.12 | 7.0 |

### Judge Notes

- **Gemini 3.1 Pro Preview** (A = GPT-6 Astra (high) (CON); B = Claude Sonnet 5 (high) (PRO)): Side A won by systematically dismantling Side B's core weighing mechanism. Side A successfully argued that Side B was conflating the baseline risk of a condition (suicide) with the proven effect size of the treatment, while correctly defending that the burden of proving net positive outcomes falls on the affirmative.
  Most decisive rebuttal noted: Side A's second rebuttal correctly identified that a severe possible outcome (suicide) does not automatically outweigh a less severe treatment harm unless the probability that the treatment actually prevents it is established.
- **Grok 4.5 (high)** (A = Claude Sonnet 5 (high) (PRO); B = GPT-6 Astra (high) (CON)): CON kept the proposition's actual comparison live: PRO had to show mental-health gains from medical care itself outweigh long-term harms, not that dysphoria is serious or that a mechanism is plausible. PRO never closed the confounding/attribution gap and repeatedly treated untreated-condition severity (especially suicide) as if it were a demonstrated treatment effect, then resolved residual uncertainty with a default-to-access rule. CON's symmetric burden, honest Pressure answers, and closing crystallization of that error made the vote clearer.
  Most decisive rebuttal noted: B2/B4 on suicide: severity of untreated risk is not an attributable treatment benefit without a comparator holding support constant; PRO's later "plausibly reduces background risk" concession sealed it.
- **Muse Spark 1.1 (high)** (A = GPT-6 Astra (high) (CON); B = Claude Sonnet 5 (high) (PRO)): CON wins the central clash on causal inference. PRO concedes in B4.1 it weighs suicide as a background risk treatment only "plausibly reduces" without isolating effect vs equally supportive care, and treats severity of untreated dysphoria as evidence of benefit. CON repeatedly shows low regret does not equal low harm, supportive care must be held constant, and disclosure does not eliminate lasting harms, with clean A1/A2 answers under pressure while PRO's answers evade the effect-size question. Under the proposition's explicit benefit-versus-harm comparison, plausibility plus asymmetry cannot substitute for attributable gain.
  Most decisive rebuttal noted: A2.1-A2.4 / A4.3 – CON exposes that PRO counts the whole supportive package as medical benefit and conflates severity of suicide risk with size of treatment effect, a concession PRO repeats in B4.

## Debate B

- Transcript: [read the full debate](../../../transcripts/prop_0107__gpt-6-astra-high__claude-sonnet-5-high__s1__tpl_placement_active_20260813a.md)
- Roles: PRO = **GPT-6 Astra (high)**, CON = **Claude Sonnet 5 (high)**
- Judged result: Split `2-1` for **Claude Sonnet 5 (high)**.
- Entertainment scores: `9`, `7`, `7`
- Mean signed raw margin (PRO+): `-0.73`

| Judge | Presented sides | Winner | Signed Margin (PRO+) | Normalized | Entertainment |
| --- | --- | --- | ---: | ---: | ---: |
| Gemini 3.1 Pro Preview | A = Claude Sonnet 5 (high) (CON); B = GPT-6 Astra (high) (PRO) | Claude Sonnet 5 (high) | -2.2 | -1.87 | 9.0 |
| Grok 4.5 (high) | A = GPT-6 Astra (high) (PRO); B = Claude Sonnet 5 (high) (CON) | Claude Sonnet 5 (high) | -1.5 | -1.70 | 7.0 |
| Muse Spark 1.1 (high) | A = Claude Sonnet 5 (high) (CON); B = GPT-6 Astra (high) (PRO) | GPT-6 Astra (high) | +1.5 | +1.59 | 7.0 |

### Judge Notes

- **Gemini 3.1 Pro Preview** (A = Claude Sonnet 5 (high) (CON); B = GPT-6 Astra (high) (PRO)): Side A won by ruthlessly holding Side B to the proposition's burden of proof and successfully trapping B on the definition and evidence of 'carefully screened' access. A's 'fork' argument in Rebuttal 2 masterfully neutralized B's best point about blockers, leaving B unable to claim the safety of a pause while relying on the benefit data of irreversible hormone pathways.
  Most decisive rebuttal noted: A's Rebuttal 2 perfectly answered B's pressure questions, using the 'fork' analogy to force B to choose between reversible blockers (which lack B's benefit data) and irreversible hormones (which invite A's harm arguments).
- **Grok 4.5 (high)** (A = GPT-6 Astra (high) (PRO); B = Claude Sonnet 5 (high) (CON)): CON won the decisive clash on burden and population definition. PRO needed net benefit over long-term regret/harm for a reliably screened group; CON forced concessions that long-term ledger data are thin and that no validated criterion predicts lifelong persistence, then used the blockers-to-hormones fork to stop PRO from mixing reversible-pause safety with full-pathway benefit claims. PRO’s best counters—that delay is not neutral and that screening need not be clairvoyance—kept it competitive but did not restore the comparative proof the motion requires. Two clipped CON turns were an execution cost, not enough to reverse the clearer path to victory.
  Most decisive rebuttal noted: B’s Rebuttal 2 fork: PRO cannot simultaneously borrow the safety of a reversible blocker pause and the mental-health evidence from cohorts who proceeded to hormones.
- **Muse Spark 1.1 (high)** (A = Claude Sonnet 5 (high) (CON); B = GPT-6 Astra (high) (PRO)): B wins because it dismantles CON's central "preserves every future option" frame and shows delay also forecloses options via irreversible puberty. CON concedes blockers as sensible pause, but B shows blockers are the gender-affirming access in dispute, collapsing CON's alternative. CON's strongest push - no validated lifelong predictor - is answered by B's reframing of screening as error-reduction, not clairvoyance, with safeguards acknowledged. A is also penalized for two clipped turns, leaving its fork argument incomplete. Weighing of imperfect positive follow-up + mechanism + harm of untreated dysphoria vs uncertainty alone is cleaner for PRO.
  Most decisive rebuttal noted: B's Rebuttal 1/2 chain: puberty proceeds during waiting so withholding is not neutral, plus CON's "reversible pause" is itself gender-affirming care - exposing inconsistency in CON's pipeline critique and collapsing the watchful-waiting vs treatment binary.

## Technical metadata

- Evaluation scope: `judge_judge_blend_glm53_coverage_20260904a__debate_all_templates`
- Topic ID: `prop_0107`
- Side-swap group ID: `prop_0107__claude-sonnet-5-high__gpt-6-astra-high__tpl_placement_active_20260813a`
- Raw paired winner: **GPT-6 Astra (high)**
- Mean normalized margin for Claude Sonnet 5 (high): `-0.60`
- Complete side swap: `yes`
- Included in ratings: `yes`
